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OBJECTIVE—Long-term implications of childhood obesity and BMI change over the life
course for risk of type 2 diabetes remain uncertain. The objective was to establish whether there
are effects on adult glucose metabolism of 1) sensitive periods of BMI gain or 2) long duration of
overweight and obesity.
RESEARCH DESIGN AND METHODS—Participants in the 1958 British birth cohort
with child to adult BMI and glycosylated hemoglobin (HbA1c) at 45 years (n = 7,855).
RESULTS—Prevalence of type 2 diabetes or HbA1c $7 was 2%. BMI gains in child- and
adulthood were associated with higher HbA1c: for every SD of 5-year BMI increase from 0 to 7
years, there was a 75% (95% CI 1.42–2.16) increased risk of HbA1c$7, increasing to a 4.7-fold
(3.12–7.00) risk for the interval 23–33 years. Associations for BMI gain in adulthoodwere related
to attained BMI but were independent for the longer period birth (or 7 years) to 45 years.
Duration of obesity was also associated with HbA1c; compared with the never obese, those with
childhood onset had a 23.9-fold risk (13.5–42.1) of HbA1c $7%; odds ratios were 16.0 (10.6–
24.2) and 2.99 (1.77–5.03), respectively, for young and midadulthood onset. Similar trends by
onset age were found in mean HbA1c levels and for onset of overweight. Those with the earliest
age of onset had higher BMI and waist circumference at 45 years, which markedly explained the
associations for onset age and HbA1c.
CONCLUSIONS—Excessive BMI gain across the life span and earlier onset of overweight/
obesity are associated with impaired glucose metabolism, in part through attained adult BMI.
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The global and societal implicationsof the type 2 diabetes epidemic arerecognized increasingly, with reduc-
tions in life expectancy and increased ill-
health burden. Thinness and accelerated
weight gain in childhood (1–4) and weight
gain in adulthood (5,6) have been found to
affect glucose tolerance or risk of type 2
diabetes. Thus, weight gain over different
life stages from early childhood is impli-
cated in the development of type 2 diabe-
tes, but uncertainty remains about whether
some life stages are more inﬂuential than
others. There is also some evidence that
longer duration of adiposity may increase
the risk of type 2diabetes (6–9), from studies
that are mostly limited to small samples (9)
or to retrospective recall of weight from
midadulthood (6,8). Evidence on duration
of adiposity therefore lacks a ﬁrm founda-
tion, although it is urgently needed given
that a growing number of adults will be
overweight or obese for long periods of
their lives as a result of increased prevalence
of childhood overweight in many popula-
tions (10). Large population-based studies
with repeated adiposity measures are re-
quired to conﬁrm or refute claims about
the timing and duration of adiposity gain
and to determine effect sizes. We therefore
examined the inﬂuence of adiposity gain
over the life course on glucose metabolism
in midadulthood in a British population.
Our aims were to establish whether there
are 1) sensitive or critical periods of adipos-
ity gain for glucose metabolism in mid-
adulthood and 2) long-lasting effects of
childhood overweight (or obesity), either
in the absence of or with persistence (du-
ration) of overweight (or obesity) intomid-
adulthood.
RESEARCH DESIGN AND
METHODS
Study sample
The 1958 cohort consists of 17,638 indi-
viduals born one week in March 1958
in England, Scotland, and Wales and en-
rolled at birth with 920 immigrants re-
cruited during childhood; this is largely a
white European population (98%). Survi-
vors were seen at ages 7, 11, 16, 23, 33, 42,
and 45 years. The 45-year survey included
physical assessments and nonfasted ve-
nous blood collection, to which all partici-
pants gave written informed consent;
ethical approval was given by the South-
East Multi-Centre Research Ethics Com-
mittee. Details of the 45-year study are
provided elsewhere (11). In brief, 11,971
cohort members who were still living
in the U.K. and in contact with the study
were invited to a clinical assessment at 45
years; 9,377 participated. These partici-
pants were broadly similar to the original
birth population but with slight underrep-
resentation of some groups (e.g., those
with poor cognitive ability) (12). Individ-
uals with type 1 diabetes (59 self-reported
at 42 years and 8 prescribed insulin at 45
years, British National Formulary code
060101) were excluded, leaving 9,310
participants, of whom 7,855 had glycosy-
lated hemoglobin (HbA1c) and diabetes
medication data at 45 years.
Measures
HbA1c was measured using high perfor-
mance liquid chromatography and the re-
sults standardized to the Diabetes Control
and Complications Trial as described pre-
viously (13). HbA1c was analyzed as a con-
tinuous variable and as twobinary variables
using cutoffs 7% (3 SDs above the mean)
and 6% (2 SDs) (14). Individuals with type
2 diabetes were grouped with HbA1c $7.
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A total of 155 cases were identiﬁed from
1) self-reports at 42 years that a doctor
had told them that they had “non–insulin-
dependent diabetes that is controlled by
diet or tablets” (n = 67), 2) oral antidiabetic
drugs at 45 years (n = 108, British National
Formulary code 060102), and 3)HbA1c$7
(n = 116). Thus, there was overlap of the
three sources of identiﬁcation, with only
13 individuals classiﬁed from self-report
alone. Other studies found self-reports to
agree well with information from other
sources (15,16).
BMIwas calculated at each age (kg/m2).
Thinness, overweight, and obesity in child-
hood were deﬁned using international
BMI cutoffs (17); for adulthood, thin-
ness (moderate) was deﬁned as #17,
overweight as $25, and obesity as $30
kg/m2. Age of onset of overweight was
identiﬁed as the ﬁrst age when BMI was
deﬁned as overweight (including obese);
in a similar manner, categories were de-
rived for obesity onset (details are given
in table footnotes). Waist circumference
at 45 years was measured midway be-
tween the costal margin and iliac crest to
the nearest 1 mm. Birth weight for gesta-
tional age was calculated as birth weight
standardized within gestational week.
Family history of diabetes, ethnicity, social
class in childhood, plus social class, edu-
cation level, smoking and alcohol con-
sumption (42 years), and total and HDL
cholesterol (45 years), were considered as
potential confounding factors.
Analysis
Main analyses examined associations be-
tween BMI and HbA1c using linear and
logistic regression for HbA1c as a contin-
uous or dichotomous ($7, including type
2 diabetes) outcome, respectively. Models
of HbA1c (continuous) were ﬁtted using
robust variance estimation and were ad-
justed for type 2 diabetes treatment. We
tested whether associations between BMI
and HbA1c differed for men and women
using an interaction term for sex.
Sensitive or critical periods of BMI
gain. Sex-speciﬁc SD scores (z scores)
were calculated for BMI at each age be-
cause the distribution of BMI changes
with age (Table 1). Birth weight for gesta-
tional age was also converted to a z score.
Table 1—Elevated HbA1c (%) and mean HbA1c at age 45 years by BMI at several ages, child- to adulthood (n = 7,855)
n (%) Mean (SD)
BMI at 45 years
mean (SD)
HbA1c geometric
mean (SD)
HbA1c $7‡
n (%) OR (95% CI)
Men 3,937 (50.1) 27.7 (4.2) 5.26 (0.64) 95 (2.4) —
Women 3,918 (49.9) 26.9 (5.5) 5.14 (0.64) 60 (1.5) —
BMI at 7 years# 15.8 (1.7)
Thin 140 (2.2) 26.1 (4.6) 5.23 (0.50) 2 (1.4) 0.9 (0.2–3.5)
Normal 5,631 (88.6) 27 (4.6) 5.19 (0.48) 94 (1.7) 1.0
Overweight 480 (7.6) 29.8 (5.9) 5.27 (0.68) 23 (4.8) 3.0 (1.9–4.7)
Obese 104 (1.6) 34.3 (7.7) 5.31 (0.66) 6 (5.8) 3.6 (1.5–8.4)
BMI at 11 years# 17.3 (2.4)
Thin 92 (1.5) 23.8 (3.7) 5.21 (0.35) 0 (0) —
Normal 5,579 (89.6) 26.9 (4.5) 5.19 (0.46) 83 (1.5) 1.0
Overweight 475 (7.6) 31.5 (6.3) 5.30 (0.68) 26 (5.5) 3.8 (2.4–6.0)
Obese 82 (1.3) 33.7 (6.9) 5.57 (1.11) 10 (12.2) 9.2 (4.6–18.4)
BMI at 16 years# 20.6 (2.7)
Thin 105 (1.8) 23 (3.1) 5.18 (0.35) 1 (1) 0.8 (0.1–5.5)
Normal 5,117 (89.4) 26.8 (4.4) 5.18 (0.43) 64 (1.3) 1.0
Overweight 433 (7.6) 32.3 (5.9) 5.36 (0.77) 29 (6.7) 5.7 (3.6–8.9)
Obese 71 (1.2) 37.3 (7.9) 5.89 (1.49) 18 (25.4) 26.8 (14.9–48.3)
BMI at 23 years§ 22.5 (2.9)
Thin 52 (0.8) 21 (3.1) 5.11 (0.29) 0 (0) —
Normal 5,638 (84.2) 26.3 (3.9) 5.16 (0.41) 53 (0.9) 1.0
Overweight 856 (12.8) 32.2 (4.7) 5.35 (0.71) 42 (4.9) 5.4 (3.6–8.2)
Obese 147 (2.2) 39.4 (6.1) 5.85 (1.27) 31 (21.1) 28.2 (17.4–45.5)
BMI at 33 years§ 24.9 (4.1)
Thin 28 (0.4) 22.7 (3.5) 5.16 (0.35) 0 (0) —
Normal 4,019 (58.4) 24.8 (3) 5.12 (0.35) 16 (0.4) 1.0
Overweight 2,191 (31.9) 29.5 (3.4) 5.23 (0.50) 37 (1.7) 4.3 (2.4–7.7)
Obese 640 (9.3) 35.8 (5.6) 5.54 (0.95) 68 (10.6) 29.7 (17.1–51.6)
BMI at 45 years§ 27.3 (4.9)
Thin 8 (0.1) 16.4 (0.8) 5.13 (0.28) 0 (0) —
Normal 2,733 (34.8) 22.7 (1.7) 5.11 (0.35) 11 (0.4) 1.0
Overweight 3,236 (41.2) 27.3 (1.4) 5.17 (0.42) 37 (1.1) 2.9 (1.5–5.6)
Obese 1,868 (23.8) 34.1 (4) 5.40 (0.74) 105 (5.6) 14.7 (7.9–27.5)
All trends are statistically signiﬁcant (P, 0.001) across categories of BMI. ‡Includes known type 2 diabetes. #BMI in childhood classiﬁed using international age and
sex-speciﬁc cutoffs (17,25): thinness (moderate, i.e., grade 2), respectively, for ages 7, 11, and 16 years as 13.08, 13.72, and 16.08 kg/m2 for boys and 12.91, 13.79,
and 16.44 kg/m2 for girls; overweight, respectively, as $17.92, $20.55, and $23.90 kg/m2 for boys and $17.75, $20.74, and $24.37 kg/m2 for girls; and
obesity, respectively, as$20.63, $25.10, and $28.88 kg/m2 for boys and$20.51,$25.42, and$29.43 kg/m2 for girls. §BMI in adulthood, cutoff for thinness
(grade 2) is #17 kg/m2; for overweight, $25 kg/m2; and for obesity, $30 kg/m2.
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To examine BMI gain over different age
intervals, HbA1c outcomes were regressed
on zBMI at each age, conditioned on zBMI
at the previous age. For example, the
model for the interval 7–11 years is spec-
iﬁed as: HbA1c = a + b zBMI7 + c zBMI11.
To allow for varying age intervals, we re-
parameterized this model so that increase
of zBMI between each age is expressed as
a rate of change per 5 years:
HbA1c ¼ aþ

bþ czbmi7þ

c  L
5

3

5  ðzbmi112 zbmi7Þ
L

where L is the number of years (e.g., 7–
11 years, L = 4). Thus, the coefﬁcient
(c*L/5) can be interpreted as the esti-
mated change in HbA1c per SD increase
in BMI per 5 years for the interval 7–11
years, given BMI at 7 years, and accord-
ingly, representing the change in relative
position in the distribution between ages.
Odds ratios (ORs) estimated for dichot-
omous outcomes were similarly adjusted
to allow for varying age intervals (i.e.,
ORL/5). To assess the effect of change in
BMI over longer periods from the earliest
ages to 45 years, we examined models of
BMI at each age adjusted for BMI at 45
years: the model HbA1c = a + c zBMI7 +
d zBMI45 was used to estimate change in
HbA1c associated with an SD increase in
BMI at 7 years. When rewritten as HbA1c =
a2 c (zBMI452 zBMI7) + (c + d) zBMI45,
we interpret 2 c as the estimated effect
of an SD increase in BMI, 7–45 years,
allowing for BMI at 45 years. If c is neg-
ative, this indicates that HbA1c will be
higher in association with BMI gain (e.g.,
7–45 years); if c is positive, HbA1c will be
lower in association with BMI gain. All
models were adjusted for sex, family his-
tory of diabetes, ethnicity, and social class
in childhood and adulthood. To deter-
mine whether early BMI modiﬁes the as-
sociation between concurrent BMI and
HbA1c, we examined associations between
BMI at 45 years and HbA1c, stratiﬁed by
BMI categories (i.e., lowest 10%, 10–50%,
50–90%, and highest 10%) in childhood
with a test of the interaction between early
and concurrent BMI.
Age of onset (overweight or obesity).
We examined associations between age of
obesity onset and HbA1c using “never
obese” as the reference group. Trends
across onset groups representing increas-
ing duration of obesity were tested. Anal-
yses were repeated for onset of overweight,
including obesity. Models were adjusted
for family history of diabetes, social class
in childhood and adulthood, education,
smoking, alcohol consumption, meno-
pausal status, total and HDL cholesterol,
BMI, and waist circumference.
Missing data. To minimize any bias asso-
ciated with missing data and to maximize
precision of results, we used the multiple
imputation by chained equations (MICE)
procedure in STATA version 10.1. A total
of 10 imputed datasets were created using
20 cycles per imputation. Variables in im-
putation models included all model vari-
ables plus key predictors of missing data
previously identiﬁed: social class at birth
and in adulthood and cognitive ability and
behavior problems at 7 years (12). BMI
z scores and onset variables were derived
from imputed BMI within each dataset;
distributions were similar for observed
and imputed values. We compared results
from multiple imputations to those from
complete case analyses and found similar
results. In general, associations for com-
plete case analyses were stronger with
wider CIs, although adjustment for con-
current adiposity reduced associations to
a similar degree. Imputed results are pre-
sented.
All analyses for elevated HbA1c were
repeated using a lower threshold ($6, in-
cluding type 2 diabetes) to conﬁrm the
pattern of results in a larger group, as pre-
sented in the Supplementary Tables.
RESULTS—Of 45-year-olds, 2% had
HbA1c $7% or had been diagnosed with
type 2 diabetes (Table 1). A further 2.0%
had HbA1c 6–6.9%. Men had higher
HbA1c than women (median = 5.2 and
5.1, respectively) and more had HbA1c
$7%. For all ages, those who were over-
weight or obese hadmore than double the
risk of elevated HbA1c, and there were
trends in HbA1c levels across categories of
BMI. Associations were found to be similar
for men and women and, thus, combined
analyses are presented (adjusted for sex).
Change in BMI and adult HbA1c
For each separate age interval, an increase
in BMI was associated with higher HbA1c
at 45 years, after allowing for BMI at the
start of the interval, which strengthened
with age (Table 2). For example, from 0 to
7 years, for every SD of 5-year BMI gain,
there was a 78% increased risk of HbA1c
$7, which strengthened to a ﬁvefold risk
for 23–33 years. An exceptionwas for 33–
45 years, where no association was found
for HbA1c$7, although BMI gain was as-
sociated with higher mean HbA1c and a
fourfold increased risk for the lower
threshold of HbA1c $6 (Supplementary
Table 1). This exception may be the result
of weight loss related to diabetes onset for
some individuals; individuals with type 2
diabetes increased on average from 31.6
to 32.9 kg/m2 at age 33–45 years, com-
pared with 24.9 to 27.3 kg/m2 among
Table 2—ORs for elevated HbA1c ‡7 at 45 years and difference in HbA1c (%) per SD of
5-year BMI change during different life periods adjusted for baseline BMI and per SD
of BMI at each age adjusted for BMI at 45 years (n = 7,855)
HbA1c $7†
OR (95% CI)
HbA1c§ difference
(95% CI)
BMI change between ages (years)
adjusted for baseline BMI
Birth to 7 1.75 (1.42–2.16) 0.029 (0.008–0.050)
7–11 1.66 (1.45–1.90) 0.040 (0.020–0.061)
11–16 2.06 (1.69–2.51) 0.042 (0.013–0.070)
16–23 2.99 (2.31–3.87) 0.095 (0.063–0.127)
23–33 4.67 (3.12–7.00) 0.205 (0.142–0.268)
33–45 1.24 (0.74–2.07) 0.155 (0.092–0.218)
BMI SD score, adjusted for BMI at
age 45 years, for ages (years)
0 0.90 (0.75–1.07) 20.024 (20.037 to 20.011)
7 1.02 (0.86–1.21) 20.015 (20.030 to 0.000)
11 1.21 (1.03–1.43) 20.005 (20.023 to 0.013)
16 1.44 (1.23–1.68) 20.002 (20.025 to 0.021)
23 1.83 (1.52–2.21) 0.004 (20.019 to 0.027)
33 2.56 (2.08–3.14) 0.048 (0.012–0.085)
All models adjusted for sex, social class in childhood and at 42 years, family history of diabetes, and ethnicity.
Results estimated usingmultiple imputation. †Includes diagnosed type 2 diabetes. §Models control for type 2
diabetes treatment.
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others.When associations were examined
for BMI change over longer periods, we
found that allowing for concurrent (45-
year) BMI gain 0–45 years and 7–45 years
was associated with higher HbA1c by 0.02
for every SD increase in BMI, but there
was no effect on HbA1c $7 (Table 2).
From 11 years onward, BMI gain was as-
sociated with reduced risk of HbA1c $7,
given concurrent BMI; for example, the
OR was 0.39 (95% CI 1–2.56) for a 1
SD increase in BMI, 33–45 years. In anal-
yses of the association between concur-
rent BMI and HbA1c, stratiﬁed by
childhood BMI, there was some evidence
of a strengthening association from the
lowest to the highest BMIs at 11 years
but no modifying effect for HbA1c $7
(Supplementary Table 2).
Age of (overweight or obesity) onset
Of the population, ;25% were obese by
45 years, most (59%) with onset in mid-
adulthood, whereas 7.6% were obese
from childhood (Table 3). There was an
increasing trend in mean BMI at 45 years
with longer obesity duration; waist circum-
ference also differed, by almost 10 cm
on average, between child- and mid-
adulthood onset groups. Duration of obe-
sity was associated also with all HbA1c
outcomes (trend P , 0.05); for example,
those with childhood onset had a 24-fold
increased risk of HbA1c$7 versus a 3-fold
risk for midadulthood onset (Table 3).
Adjustment for adiposity and other factors
substantially reduced, but did not entirely
eliminate, the associations and trend for
HbA1c $7. For those obese in childhood,
only a ﬁvefold increased risk of HbA1c$7
persisted after adjustment. Similar trends
were found for HbA1c $6; however, the
association for onset of obesity in child-
hood was almost abolished after adjust-
ment (Supplementary Table 3). Mean
HbA1c levels were also higher with longer
duration of obesity, with substantial re-
ductions after adjustment, but individuals
with childhood obesity only did not have
higher levels. An estimated 68% of the
population was overweight by 45 years,
with onset commonly in early adulthood
or in childhood (Table 3). Patterns of
results were similar, albeit weaker, when
duration of overweight was examined;
hence, associations were largely abolished
after adjustment.
CONCLUSIONS—Our population-
based study of BMI from early life and
adult glucose metabolism provides three
main ﬁndings. First, excessive BMI gain at
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P
,
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and
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ild
hood
only).
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all life stages was associated with elevated
HbA1c levels, cumulatively across the life
span. When concurrent (45-year) BMI is
taken into account, associations for adult
BMI gain appeared to be largely due to
their effect on attained BMI, whereas
BMI gain from the ﬁrst decade of life re-
mained associated with mean HbA1c lev-
els and HbA1c $6%, although not HbA1c
$7%. Second, adults with overweight or
obesity onset in childhood or young
adulthood had the highest mean BMIs
and waist circumference at 45 years and
greatest risk of elevated HbA1c. Child-
hood obesity onset was associated with
an almost 24-fold risk of HbA1c $7%
compared with the never obese, and there
was a 22-fold risk for the more prevalent
group with childhood overweight onset.
Associations between earlier onset of
overweight or obesity and adult HbA1c
levels were largely due to the greater adi-
posity at 45 years of those with earlier
onset. These ﬁndings are important given
recent increasing trends in overweight
and obesity in many countries (10).
Young children today are overweight ear-
lier in their lives than previous genera-
tions, including our cohort. Third, for a
minority of overweight children who
were not overweight in adulthood, mean
levels and risk of HbA1c $6% were not
elevated, suggesting that detrimental ef-
fects of childhood overweight can be
averted if BMI gain with increasing age
can be controlled. However, those who
were obese in childhood and not there-
after had a ﬁvefold risk of HbA1c $7%
or type 2 diabetes.
Glucose metabolism is indicated by
HbA1c (13,16) because it was impractical
to obtain fasting samples in this working-
age population, resident throughout the
U.K. Reassuringly, prevalence of type 2
diabetes is comparable to other U.K. stud-
ies using different data ascertainment
methods (13), although at 45 years this
is an uncommon outcome. A threshold
of 7% is associated with a diagnosis of
type 2 diabetes based on the oral glucose
tolerance test (18); although a continuum
of risk has been demonstrated for type 2
diabetes (16), and for cardiovascular dis-
ease andmortality (19), justifying analysis
of HbA1c as a continuous variable. Re-
garding clinical signiﬁcance, others have
shown that among women with baseline
HbA1c $7 and 6.0–6.9%, respectively,
81.1 and 60% developed diabetes within
10 years’ follow-up (16). Our results for
HbA1c $7% were conﬁrmed for a larger
group with HbA1c$6%. BMI change was
assessed using repeated prospective
measures rather than the retrospective re-
ports of some previous studies (5,6,8,20).
A further advantage is prospectively mea-
sured birth weight, to assess body size
changes from birth to 7 years, although
our lack of early life measures is a limita-
tion. Some bias in the participating adult
sample has arisen in association with loss
to follow-up, although less so for factors
examined here than for others (12). A fur-
ther source of missing data is item non-
response; hence, we conducted analyses
using imputation.
Changes in BMI, child- to adulthood
Studies of type 2 diabetes have mainly
focused on weight or BMI change dur-
ing child- or adulthood, and such studies
cannot elucidate whether some ages are
more important than others. Our study of
multiple intervals over an individual’s
lifetime shows that excessive BMI gain at
every life stage was associated with HbA1c
levels at 45 years. Because we allowed for
BMI at the beginning of each age interval,
our analyses separate associations for BMI
gain during each interval from prior BMI.
Strong effects of adult adiposity gain are
suggested by the literature. For example,
those 40- to 59-year-old men gaining
.10% of their weight had a two- to three-
fold increased risk of type 2 diabetes com-
pared with men whose weight remained
stable (6). With risk of HbA1c $7% of
more than fourfold for an SD gain in
BMI per 5 years over the interval 23–33
years, our study conﬁrms the importance
of adult adiposity gain for risk of diabetes.
As reported elsewhere (21), our ﬁndings
suggest that adult BMI gains are associ-
ated with glucose metabolism via BMI at-
tained in midadulthood. Indeed, lower
HbA1c was observed for some life stages,
after we had taken account of concurrent
BMI, which may be partly the result of
disease-related weight loss. (In the absence
of HbA1c measurement at earlier life
stages, we are unable to assess this possi-
bility.) But higher HbA1c associated with
BMI gains over longer periods, from the
ﬁrst decade of life to 45 years, was not
because of concurrent BMI. Despite the
lack of an association for HbA1c $7%,
our study suggests that BMI gain in the
ﬁrst decade may be important outside
any inﬂuence of gain on adult adiposity.
Thus, our results are compatible with
others’ (2,4) suggesting that accelerated
weight gain in childhood inﬂuences dia-
betes risk, even in the absence of obesity
(2), although we found no support for
associations with thinness in childhood
(1). We were unable to examine narrow
intervals to test the argument that rapid
weight gain in the ﬁrst 2 weeks of life is a
sensitive period for risk of diabetes (22). Yet
we previously demonstrated an inverse as-
sociation of birth weight with diabetes risk
and HbA1c levels in this population, show-
ing the greater risk among those with small
size at birth to be dependent on subsequent
weight gain (23,24). Our ﬁndings for BMI
gain during different life stages may corre-
spond to different changes in body compo-
sition, with changes in lean mass possibly
more involved in BMI change in childhood
than in adulthood.
Duration of adiposity
A dose-response relationship was found
for overweight and obesity duration with
elevated HbA1c in midadulthood; associ-
ations strengthened from those with the
shortest to the longest duration, the latter
identiﬁed as onset from childhood. Our
study therefore adds to previous studies
suggesting an association between over-
weight duration and diabetes or impaired
glucose tolerance (9). Our ﬁndings are
also consistent with the possibility that
those with longer overweight duration
have greater abdominal obesity (8). Be-
cause elevated levels of HbA1c associated
with longer duration of overweight or
obesity were largely attenuated after ad-
justment for current BMI and waist cir-
cumference, our study suggests that
alterations in glucose metabolism for
this group are primarily the result of their
greater adiposity. Positive associations
were markedly reduced but persisted for
HbA1c $7 after adjustment for several
factors, including current adiposity, sug-
gesting that there may be some residual
confounding or alternatively, some effect
of adiposity duration. Our ﬁndings from
stratiﬁed analysis, suggesting a strength-
ening association between concurrent
BMI and HbA1c, from the lowest to the
highest childhood BMIs, may be relevant
here. These results (although not seen for
HbA1c $7) provide some support for an
effect of longer duration on glucose me-
tabolism. It has been argued that duration
of obesity decreases glucose tolerance by
way of progressively increased insulin re-
sistance and with long duration, with
decreased insulin secretion (20), but un-
derlying biological mechanisms remain
unclear.
It is important that for a minority of
overweight children who were not over-
weight later in life, HbA1c was not elevated
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relative to those who had never been over-
weight. A similar ﬁnding has been reported
for metabolic syndrome, although using
lower cutoffs for overweight (7). Our study
suggests that outcome depends on BMI
threshold, with a ﬁvefold risk of elevated
HbA1c among those with obesity in child-
hood only, suggesting a long-lasting risk
for impaired glucose metabolism even in
the absence of adult obesity. This ﬁnding
could be due to overweight in adulthood
(72% at 45 years); although adjustment for
adiposity at 45 years did not explain the
association, and other factors in childhood
may be important. If conﬁrmed in other
studies, this ﬁnding argues for primary pre-
vention in childhood.
Associations observed in this study
suggest that there are beneﬁts of delaying
onset of overweight and obesity, in that
risks of elevated HbA1c were lower for 45-
year-olds becoming overweight or obese
in the previous 12 years than for earlier
onset. Arguably, therefore, interventions
to prevent obesity are best targeted in
childhood. Moreover, normal weight
groups in our study population who
gained BMI excessively were at risk for
elevated HbA1c, albeit via their attained
BMI, suggesting that weight gain across
the full distribution should be a focus for
preventive strategies for type 2 diabetes.
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